← Eichor
Study identifier: NCT03797690 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Effectiveness of Percutaneous Needle Aponeurotomy

Condition: Dupuytren Disease of Finger  ·  Sponsor: Assistance Publique - Hôpitaux de Paris

PhaseNA
Planned participants120
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The main objective is to investigate if percutaneous needle aponeurotomy is non-inferior to open surgery using aponeurectomy in treatment of flexion contracture due to Dupuytren's disease. Our hypothesis is that percutaneous needle aponeurotomy has suitable efficacy and safety profile for large application in the treatment of Dupuytren's disease and that it is consequently able to drastically reduce the need of open surgery in this indication.

This description comes directly from the study's public registry record.

Talk to the study team

Johann BEAUDREUIL, PUPH  ·  +33 1 49 95 88 28  ·  johann.beaudruil@aphp.fr

Always discuss trial participation with your own doctor first.

Locations (4)

Centre d'Imagerie Médicale Bachaumont Paris CentreParis, FranceActive Not Recruiting
Hopital LARIBOISIERE - RadiologieParis, FranceActive Not Recruiting
Hopital LARIBOISIERE - RhumatologieParis, FranceRecruiting
JOUVENET - Orthopédie, chirurgie de la main et du membre supérieurParis, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03797690